First application of preimplantation genetic diagnosis to neurofibromatosis type 2 (NF2)

Prenatal Diagnosis

Volumn 22, Issue 6, 2002, Pages 519-524

  Abou Sleiman, P M ^a,c   Apessos, A ^a   Harper, J C ^a   Serhal, P ^a   Winston, R M L ^b   Delhanty, J D A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Fluorescent SSCP; Neurofibromatosis type 2; NF2; Preimplantation genetic diagnosis (PGD); Single cell PCR

Indexed keywords

ADULT; ARTICLE; BASE MISPAIRING; CANCER RISK; CASE REPORT; CYTOLYSIS; DNA SEQUENCE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GENE AMPLIFICATION; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SCREENING; HUMAN; INTRON; MALE; NEUROFIBROMATOSIS; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; BIOPSY; BLASTOMERES; DNA MUTATIONAL ANALYSIS; EMBRYO TRANSFER; FERTILIZATION IN VITRO; GENES, NEUROFIBROMATOSIS 2; HUMANS; MALE; MUTATION; NEUROFIBROMATOSIS 2; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREIMPLANTATION DIAGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 0036296668     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.393     Document Type: Article

References (13)

1. Pregnancy following preimplantation genetic diagnosis for Crouzon syndrome
2. Preimplantation genetic diagnosis of the fragile X syndrome by use of linked polymorphic markers
3. A genetic study of type 2 neurofibromatosis in the United Kingdom. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity
4. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): Evidence for more severe disease associated with truncating mutations
5. Somatic mosaicism: A common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis
6. The diagnostic evaluation and multidisciplinary management of neurofibromatosis I and neurofibromatosis 2
7. The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2
8. Mosaicism in sporadic neurofibromatosis 2 patients
9. The parental origin of new mutations in neurofibromatosis type 2
10. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis)
11. Simultaneous evaluation of basal FSH and oestradiol response to GnRH analogue (F-G-test) allows effective drug regimen selection for IVF
12. Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother and identification of seven novel mutations in the NF2 gene
13. Single cell detection of inherited retinoblastoma predisposition